J. Bradley

Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.

P. Lambin, J. Deasy, W. De Neve, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic Body Radiotherapy for Early‐Stage Multiple Primary Lung Cancers

C. Robinson, M. Roach, J. Bradley, 2019, Clinical lung cancer.

On the design, conduct and lessons learned from Lung-MAP (SWOGS1400): A biomarker-driven master protocol to evaluate biomarker-driventherapies for previously-treated squamous lung cancer

Stacey, L. Schwartz, M. Leblanc, 2021 .

Patient Reported Outcomes in a Practice Changing Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study

L. Ramondetta, H. Michael, M. Method, 2015 .

ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

K. Rosenzweig, R. Komaki, R. Feins, 2009, Journal of the American College of Radiology : JACR.

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer

J. Galvin, H. Choy, R. Timmerman, 2018, JAMA oncology.

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.

L. Schwartz, M. Leblanc, R. Herbst, 2020, The Lancet. Oncology.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.